Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the...
Seers Inc received a bumper listing valuing it at $3.3 billion for a revenue of less than $1 million.
It is claimed that company has a breakthrough for studying proteins and for diagnostics.
Seers Inc received a bumper listing valuing it at $3.3 billion for revenue of less than $1 million. It is claimed that the company has a breakthrough for studying proteins...
